| Stephanie Stewart, LLP | |
|
5148 Lovers Ln, Suite 2, Portage, MI 49002-1572 | |
| (269) 343-3010 | |
| (269) 343-3017 |
| Full Name | Stephanie Stewart |
|---|---|
| Gender | Female |
| Speciality | Psychologist |
| Location | 5148 Lovers Ln, Portage, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386694909 | NPI | - | NPPES |
| P108927600 | Other | MI | BCBSM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | 6361002804 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Stephanie Stewart, LLP 5148 Lovers Ln, Suite 2, Portage, MI 49002-1572 Ph: (269) 343-3010 | Stephanie Stewart, LLP 5148 Lovers Ln, Suite 2, Portage, MI 49002-1572 Ph: (269) 343-3010 |
News Archive
Patients with moderate to severe sleep apnea who have significantly higher serum levels of inflammatory markers that serve as precursors to coronary artery disease, as well as lesions associated with silent brain infarction, have an elevated risk of stroke, according to a group of Japanese medical researchers.
Researchers at Purdue University have discovered a molecular mechanism that may play a crucial role in cancer's ability to resist chemotherapy and radiation treatment and that also may be involved in Alzheimer's and heart disease.
Reporting in the Lancet Psychiatry today, psychologists at the University of Bath highlight that a widely used technique for autism screening is being misused, which may have prevented many people from receiving an autism diagnosis over the past decade.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in the Crohn's disease drug market, the dominance of TNF-alpha inhibitors such as Abbott/Eisai's Humira and Centocor Ortho Biotech/Schering-Plough/Mitsubishi Tanabe's Remicade will continue over the next decade. Sales of Humira and Remicade, which accounted for more than three-quarters of the market in 2008, will continue to grow through 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
Results from a phase II clinical trial indicate a novel drug may provide a treatment option for chronic myeloid leukemia (CML) patients who do not respond to current therapies, researchers from The University of Texas M. D. Anderson Cancer Center report today at the 51st Annual Meeting of the American Society of Hematology.
› Verified 1 days ago
Patricia Shull-blood, LLP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 5148 Lovers Ln, Suite 200, Portage, MI 49002 Phone: 269-343-3010 Fax: 269-343-3017 | |
Mr. Timothy Lewis Radabaugh, MA, LLP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 742 Ludington Ave, Portage, MI 49002 Phone: 269-876-0228 | |
Lee Carlin Sanders, MA LLP LMSW Psychologist Medicare: Not Enrolled in Medicare Practice Location: 10056 Woodlawn Dr, Portage, MI 49002 Phone: 269-324-9805 | |
Dr. Kristin Rae Gillen, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1514 W Milham Ave, Portage, MI 49024 Phone: 269-342-0606 | |
Dr. Ollie Garfield Barnes Iii, ED.D Psychologist Medicare: Not Enrolled in Medicare Practice Location: 576 Romence Rd, Suite 222, Portage, MI 49024 Phone: 269-207-7373 Fax: 269-323-2282 | |
Sheri L Heflin, MA, LLP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1662 E Centre Ave, Portage, MI 49002 Phone: 269-321-8564 Fax: 269-321-8641 | |
Mr. Chad E Muffley, MA LLP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 5220 Lovers Lane, Suite 120, Portage, MI 49002 Phone: 269-344-3080 Fax: 269-344-0543 |